| Tue, Nov 24, 2009 | | • | Still Believe in Antigenics
at Seeking Alpha (Tue, Nov 24)
| | • | Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
PR Newswire (Tue, Nov 24)
| | Sat, Nov 14, 2009 | | • | KERYX BIOPHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Nov 14)
| | Wed, Nov 11, 2009 | | • | Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
PR Newswire (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
| | • | Piper Jaffray Award Winning Analyst Says Health Care Reform Equity Valuation Fears Have Passed: Stock Picks For Q4 2009
Wall Street Transcript (Tue, Nov 10)
| | • | Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | • | KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Nov 9)
| | • | Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
PR Newswire (Mon, Nov 9)
| | • | AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
PR Newswire (Mon, Nov 9)
| | Fri, Nov 6, 2009 | | • | Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
PR Newswire (Fri, Nov 6)
| | Wed, Nov 4, 2009 | | • | Keryx Biopharmaceuticals to Present at the Merriman Curhan Ford 6th Annual Investor Summit
PR Newswire (Wed, Nov 4)
| | Fri, Oct 30, 2009 | | • | One Bet You're Sure to Lose
at Motley Fool (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | • | Keryx Biopharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
PR Newswire (Thu, Oct 29)
| | Tue, Oct 27, 2009 | | • | Keryx Biopharmaceuticals' Next Price Movers Will Be Trial News
at Seeking Alpha (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | • | Tomorrow's Monster Stock?
at Motley Fool (Mon, Oct 26)
| | • | Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
PR Newswire (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | • | 5 Cold Stocks Heating Up
at Motley Fool (Fri, Oct 23)
| | Tue, Oct 20, 2009 | | • | AKT Inhibitor Moving Into Phase III Trials: Ladenburg Thalmann Sees This As Catalyst For Investors
Wall Street Transcript (Tue, Oct 20)
| | Thu, Oct 15, 2009 | | • | Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals
GlobeNewswire (Thu, Oct 15)
|
Add KERX News to My Yahoo!:
 
| |
|
1.48% Nasdaq 0.00%
Headlines
